Fluimucil is a mucolytic agent that works by breaking the disulfide bonds in mucoproteins, lowering mucus viscosity. It is indicated for treatment of respiratory conditions characterized by thick secretions such as acute and chronic bronchitis, pulmonary emphysema, cystic fibrosis, and bronchiectasis. Contraindications include severe hypertension, coronary artery disease, hypersensitivity to related drugs, and renal impairment. Potential side effects include bronchospasm, angioedema, rashes, pruritus, nausea, vomiting, fever, syncope, sweating, arthralgia, blurred vision, and liver function disturbances. Nursing considerations involve monitoring effectiveness and adverse effects, and educ
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Fluimucil is a mucolytic agent that works by breaking the disulfide bonds in mucoproteins, lowering mucus viscosity. It is indicated for treatment of respiratory conditions characterized by thick secretions such as acute and chronic bronchitis, pulmonary emphysema, cystic fibrosis, and bronchiectasis. Contraindications include severe hypertension, coronary artery disease, hypersensitivity to related drugs, and renal impairment. Potential side effects include bronchospasm, angioedema, rashes, pruritus, nausea, vomiting, fever, syncope, sweating, arthralgia, blurred vision, and liver function disturbances. Nursing considerations involve monitoring effectiveness and adverse effects, and educ
Fluimucil is a mucolytic agent that works by breaking the disulfide bonds in mucoproteins, lowering mucus viscosity. It is indicated for treatment of respiratory conditions characterized by thick secretions such as acute and chronic bronchitis, pulmonary emphysema, cystic fibrosis, and bronchiectasis. Contraindications include severe hypertension, coronary artery disease, hypersensitivity to related drugs, and renal impairment. Potential side effects include bronchospasm, angioedema, rashes, pruritus, nausea, vomiting, fever, syncope, sweating, arthralgia, blurred vision, and liver function disturbances. Nursing considerations involve monitoring effectiveness and adverse effects, and educ
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Fluimucil is a mucolytic agent that works by breaking the disulfide bonds in mucoproteins, lowering mucus viscosity. It is indicated for treatment of respiratory conditions characterized by thick secretions such as acute and chronic bronchitis, pulmonary emphysema, cystic fibrosis, and bronchiectasis. Contraindications include severe hypertension, coronary artery disease, hypersensitivity to related drugs, and renal impairment. Potential side effects include bronchospasm, angioedema, rashes, pruritus, nausea, vomiting, fever, syncope, sweating, arthralgia, blurred vision, and liver function disturbances. Nursing considerations involve monitoring effectiveness and adverse effects, and educ
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Fluimucil Mucolytic Exerts mucolytic Treatment of Contraindicated in Bronchospasm Monitor effectiveness of
Acetylcyste agent action through its respiratory affections patient with severe Angioedema therapy and advent of ine free sulfhydryl characterized by hypertension; severe. Rashes adverse/allergic effects. group which opens thick and viscous Coronary artery Pruritus Instruct patient in up the disulfide hypersecretions: disease, Nausea and appropriate use and bonds in the acute bronchitis, hypersensitivity to Vomiting, adverse effects to report. mucoproteins thus chronic bronchitis pseudoedephrine, Fever, lowering mucous and its exacerbations; acrivastine or any Syncope, viscosity. The pulmonary component; renal Sweating, exact mechanism emphysema, impairment. Arthralgia, of action in mucoviscidosis and Blurred vision, acetaminophen bronchiectasis. Disturbances toxicity is of liver unknown. It is function thought to act by providing substrate for conjugation with the toxic metabolite